Pay in 4 interest-free payments of $7.47 Learn more
Ships within 48 hours · Estimated delivery Aug 9 - Aug 14
Impact of insulin and metformin versus metformin alone on beta-cell function in youth with impaired glucose tolerance or recently diagnosed type 2 diabetes
This launch is expected to improve affordability and access, allowing broader patient adoption and giving payers a cost-effective alternative amid rising demand for obesity treatments
These therapies account for more than 50% of the company's total revenues
Glucagon-like peptide-1 (GLP-1) receptor agonists were originally developed to treat people with type 2 diabetes, entering clinical use in the mid-2000s
US$ 21.07
US$ 21.59
US$ 21.88
US$ 29.70
